Telehealth groups urge Congress, White House to extend controlled substance virtual prescribing
Healthcare DIVE September 11, 2024
More than 300 telehealth and provider organizations say time is running out for regulators to propose a rule before pandemic-era flexibilities expire at the end of the year.
Dive Brief:
- More than 300 telehealth and provider organizations are urging Congress and the Biden administration to extend pandemic-era virtual prescribing flexibilities for controlled substances before they expire at the end of the year.
- In letters sent to Congressional leaders Tuesday, the groups asked lawmakers to pass a two-year extension of the flexibilities, which allowed clinicians to prescribe some controlled substances via telehealth without an in-person evaluation. The organizations, who want the extension included in an end-of-year legislative package, also pushed the White House to work with the Drug Enforcement Administration...